• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ω-3 多不饱和脂肪酸与心理干预联合治疗轻中度抑郁症患者的双盲随机对照试验

Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.

机构信息

Graduate School of Education, Nagasaki University, Nagasaki, Japan; Center for Health and Community Medicine, Nagasaki University, Nagasaki, Japan.

Center for Health and Community Medicine, Nagasaki University, Nagasaki, Japan.

出版信息

J Affect Disord. 2019 Feb 15;245:364-370. doi: 10.1016/j.jad.2018.11.039. Epub 2018 Nov 6.

DOI:10.1016/j.jad.2018.11.039
PMID:30423463
Abstract

BACKGROUND

This study assessed whether a combined intervention of omega-3 polyunsaturated fatty acids (PUFAs) and psychoeducation better improved mild to moderate depression in workers compared to psychoeducation alone.

METHODS

This study was a double-blinded, parallel group, randomized controlled trial that compared the intervention group, receiving omega-3 fatty acids, with a control group, receiving a placebo supplement. Participants receiving omega-3 fatty acids took 15 × 300 mg capsules per day for 12 weeks. The total daily dose of omega-3 PUFAs was 500 mg docosahexaenoic acid and 1000 mg eicosapentaenoic acid (EPA). The Beck Depression Inventory®-II (BDI-II) was used to assess the severity of depression after treatment.

RESULTS

After 12 weeks of treatment, BDI-II scores were significantly lower in the placebo and omega-3 group, when compared to their respective baseline scores (Placebo: t = - 4.6, p < 0.01; Omega-3: t = - 7.3, p < 0.01). However, after 12 weeks of treatment, we found no significant difference between both groups with respect to changes in the BDI-II scores (0.7; 95% CI, - 0.7 to 2.1; p = 0.30).

LIMITATIONS

This study did not measure blood omega-3 fatty acid concentration and presented a high-dropout rate. Moreover, our results may not be generalizable to other regions.

CONCLUSIONS

The results show that a combination of omega-3 fatty acids and psychoeducation and psychoeducation alone can contribute to an improvement in symptoms in people with mild to moderate depression. However, there is no difference between the interventions in ameliorating symptoms of depression.

摘要

背景

本研究评估了与单纯心理教育相比,ω-3 多不饱和脂肪酸(PUFAs)与心理教育相结合的干预措施是否能更好地改善轻度至中度抑郁的工人。

方法

这是一项双盲、平行组、随机对照试验,比较了干预组(服用ω-3 脂肪酸)和对照组(服用安慰剂补充剂)。服用ω-3 脂肪酸的参与者每天服用 15×300mg 胶囊,持续 12 周。ω-3 PUFAs 的总日剂量为 500mg 二十二碳六烯酸和 1000mg 二十碳五烯酸(EPA)。采用贝克抑郁量表第二版(BDI-II)评估治疗后抑郁的严重程度。

结果

治疗 12 周后,安慰剂组和ω-3 组的 BDI-II 评分均明显低于各自的基线评分(安慰剂:t=-4.6,p<0.01;ω-3:t=-7.3,p<0.01)。然而,治疗 12 周后,两组之间 BDI-II 评分的变化无显著差异(0.7;95%CI,-0.7 至 2.1;p=0.30)。

局限性

本研究未测量血液中ω-3 脂肪酸的浓度,且脱落率较高。此外,我们的结果可能不适用于其他地区。

结论

结果表明,ω-3 脂肪酸与心理教育相结合以及单纯的心理教育都可以改善轻度至中度抑郁人群的症状。然而,两种干预措施在改善抑郁症状方面没有差异。

相似文献

1
Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.ω-3 多不饱和脂肪酸与心理干预联合治疗轻中度抑郁症患者的双盲随机对照试验
J Affect Disord. 2019 Feb 15;245:364-370. doi: 10.1016/j.jad.2018.11.039. Epub 2018 Nov 6.
2
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.欧米伽-3 联合舍曲林治疗冠心病患者抑郁症的随机对照试验
JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.
3
Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.ω-3 多不饱和脂肪酸与心血管疾病合并主要抑郁障碍的相关性:一项随机对照试验的结果。
Brain Behav Immun. 2020 Mar;85:14-20. doi: 10.1016/j.bbi.2019.03.012. Epub 2019 Mar 19.
4
EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.EPA 似乎比 DHA 更能发挥 ω-3 长链多不饱和脂肪酸在抑郁症治疗中的功效:来自随机对照试验的荟萃分析证据。
J Am Coll Nutr. 2009 Oct;28(5):525-42. doi: 10.1080/07315724.2009.10719785.
5
The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.ω-3多不饱和脂肪酸对有抑郁症状孕妇的同步试验(SYNCHRO):一项随机对照试验的研究方案
BMC Psychiatry. 2016 Sep 15;16(1):321. doi: 10.1186/s12888-016-1031-2.
6
Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.长链 ω-3 脂肪酸补充剂治疗心力衰竭合并抑郁患者:OCEAN 试验结果。
JACC Heart Fail. 2018 Oct;6(10):833-843. doi: 10.1016/j.jchf.2018.03.011. Epub 2018 Aug 8.
7
Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.欧米伽-3多不饱和脂肪酸(n-3 PUFAs)、合并重度抑郁症(MDD)的心血管疾病中的躯体及疲劳症状:一项随机对照试验
Brain Behav Immun. 2023 Aug;112:125-131. doi: 10.1016/j.bbi.2023.06.008. Epub 2023 Jun 9.
8
Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients.ω-3 脂肪酸对维持性血液透析患者抑郁及生活质量的影响。
Am J Ther. 2014 Jul-Aug;21(4):275-87. doi: 10.1097/MJT.0000000000000078.
9
Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.多不饱和脂肪酸(TPOP)预防创伤后应激障碍的立川项目:一项随机对照试验的研究方案。
BMC Psychiatry. 2013 Jan 5;13:8. doi: 10.1186/1471-244X-13-8.
10
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.长期补充欧米伽 3 多不饱和脂肪酸联合或不联合多领域干预对有记忆主诉的老年人认知功能的影响(MAPT):一项随机、安慰剂对照试验。
Lancet Neurol. 2017 May;16(5):377-389. doi: 10.1016/S1474-4422(17)30040-6. Epub 2017 Mar 27.

引用本文的文献

1
Understanding the research landscape of over-the-counter herbal products, dietary supplements, and medications evaluated for depressive symptoms in adults: a scoping review.了解针对成人抑郁症状评估的非处方草药产品、膳食补充剂和药物的研究现状:一项范围综述。
Front Pharmacol. 2025 Jul 15;16:1609605. doi: 10.3389/fphar.2025.1609605. eCollection 2025.
2
Efficacy and safety of electroacupuncture on treating mild to moderate first-episode depression: a study protocol for a randomized controlled trial.电针治疗轻中度首发抑郁症的疗效与安全性:一项随机对照试验的研究方案
Front Psychiatry. 2025 Feb 26;16:1521859. doi: 10.3389/fpsyt.2025.1521859. eCollection 2025.
3
Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers.
ω-3 脂肪酸与抑郁症中的神经炎症:针对损伤相关分子模式和神经生物标志物。
Cells. 2024 Oct 29;13(21):1791. doi: 10.3390/cells13211791.
4
Targeting Divergent Pathways in the Nutritional Management of Depression.靶向抑郁症营养管理中的不同途径。
Nutrients. 2024 Aug 22;16(16):2806. doi: 10.3390/nu16162806.
5
Omega-3 Polyunsaturated Fatty Acids in Depression.ω-3 多不饱和脂肪酸与抑郁症
Int J Mol Sci. 2024 Aug 8;25(16):8675. doi: 10.3390/ijms25168675.
6
Efficacy and safety of omega-3 fatty acids supplementation for anxiety symptoms: a systematic review and dose-response meta-analysis of randomized controlled trials.ω-3 脂肪酸补充剂治疗焦虑症状的疗效和安全性:随机对照试验的系统评价和剂量反应荟萃分析。
BMC Psychiatry. 2024 Jun 18;24(1):455. doi: 10.1186/s12888-024-05881-2.
7
Nutraceuticals in Psychiatric Disorders: A Systematic Review.精神障碍中的营养保健品:系统评价。
Int J Mol Sci. 2024 Apr 28;25(9):4824. doi: 10.3390/ijms25094824.
8
Omega-3 fatty acids for depression in adults.ω-3 脂肪酸治疗成人抑郁症。
Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5.
9
Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.解析ω-3多不饱和脂肪酸抗抑郁活性的分子机制:文献综述
Int J Mol Sci. 2021 Apr 22;22(9):4393. doi: 10.3390/ijms22094393.
10
Effects of n-3 Polyunsaturated Fatty Acid Supplementation in the Prevention and Treatment of Depressive Disorders-A Systematic Review and Meta-Analysis.ω-3 多不饱和脂肪酸补充剂在预防和治疗抑郁障碍中的作用:系统评价和荟萃分析。
Nutrients. 2021 Mar 25;13(4):1070. doi: 10.3390/nu13041070.